Growing Questions Over Future of Alzheimer’s Research As More Clinical Trials Fail

Feb 3, 2019 | Alzheimer, Alzheimer's Disease Trial, CNS

Alzheimer

New Atlas’ Rich Hardy writes the discontinuation of more major human clinical trials again raises doubts over whether the current hypothesis for Alzheimer’s disease is correct.  Roche/Genentech’s recent announcement to discontinue two major anti-Alzheimer’s clinical trials is further evidence of growing challenges.

0 Comments

Pin It on Pinterest